< Terug naar vorige pagina
Onderzoeker
Erik De Clercq
- Disciplines:Microbiologie, Systeembiologie, Laboratoriumgeneeskunde
Affiliaties
- Laboratorium Virologie en Chemotherapie (Rega Instituut) (Afdeling)
Lid
Vanaf1 okt 1999 → 30 sep 2013
Publicaties
491 - 500 van 562
- The cytotoxic properties and preferential toxicity to tumour cells displayed by some 2,4-bis(benzylidene)-8-methyl-8-azabicyclo[3.2.1] octan-3-ones and 3,5-bis(benzylidene)-1-methyl-4-piperidones(2009)
Auteurs: Erik De Clercq, Jan Balzarini
Pagina's: 54 - 62 - Viral DNA polymerase inhibitors(2009)
Auteurs: Graciela Andrei, Erik De Clercq, Robert Snoeck
Pagina's: 481 - 526 - NF-kappaB: the inducible factors of HIV-1 transcription and their inhibitors(2009)
Auteurs: Erik De Clercq
Pagina's: 60 - 9 - Non-nucleoside HIV-1 reverse transcriptase inhibitors Part 13. Synthesis of fluorine-containing diaryltriazine derivatives for in vitro anti-HIV evaluation against wild-type strain(2009)
Auteurs: Jan Balzarini, Erik De Clercq, Christophe Pannecouque
Pagina's: 561 - 568 - Synthesis and pharmacological evaluation of several ring-contracted amantadine analogs(2008)
Auteurs: Lieve Naesens, Erik De Clercq
Pagina's: 9925 - 9936 - Mechanism of antiviral drug resistance of vaccinia virus: identification of residues in the viral DNA polymerase conferring differential resistance to antipoxvirus drugs(2008)
Auteurs: Robert Snoeck, Erik De Clercq, Ghislain Opdenakker, Graciela Andrei
Pagina's: 12520 - 12534 - Comparisons of the influenza virus A M2 channel binding affinities, anti-influenza virus potencies and NMDA antagonistic activities of 2-alkyl-2-aminoadamantanes and analogues(2008)
Auteurs: Johan Neyts, Erik De Clercq
Pagina's: 6156 - 6160 - Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents(2008)
Auteurs: Christophe Pannecouque, Erik De Clercq
Pagina's: 2800 - 2806 - The discovery of antiviral agents: ten different compounds, ten different stories(2008)
Auteurs: Erik De Clercq
Pagina's: 929 - 53 - Clinical features and treatment of adenovirus infections(2008)
Auteurs: Liesbeth Lenaerts, Erik De Clercq, Lieve Naesens
Pagina's: 357 - 374
Patenten
1 - 7 van 7
- Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production (Inventor)
- 6-[2-(PHOSPHONOMETHOXY)ALKOXY] PYRIMIDINE DERIVATIVES HAVING ANTIVIRAL ACTIVITY (Inventor)
- Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production (Inventor)
- Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production (Inventor)
- VIRAL INHIBITORS (Inventor)
- VIRAL INHIBITORS (Inventor)
- PHOSPHONATE NUCLEOSIDES USEFUL AS ACTIVE INGREDIENTS IN PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS, AND INTERMEDIATES FOR THEIR PRODUCTION (Inventor)